Most people want to lose weight but do not know the right way to lose weight. Usually people think that to lose weight, one ...

Obesity is in the news because of a new weight-loss drug in the form of a pill that can be taken any time of day, with or ...

It has long been a well-established and well-documented fact that obesity — a complex, chronic disease which involves the ...

Currently, more than 42% of adults in the United States have obesity. Among young people, about 1 in 5 adolescents are also ...

Viking is developing what might be a game-changing medication in the segment.

Novo Nordisk shares rose by more than 5% after the Danish weight-loss drug maker said the Food and Drug Administration accepted a new drug application for a pill form of its popular Wegovy injection.

Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on the ...

A decision is expected in the fourth quarter of 2025.

Researchers have developed a revolutionary new way to find out the 'true age' of your heart using MRI. A new study shows how an MRI scan can reveal your heart's functional age -- and how unhealthy ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...